MS Drug Decision Delayed; Levodopa for Stroke Recovery; Boosting Astrocytic NAD+

(MedPage Today) — The FDA extended its decision date for investigational tolebrutinib in non-relapsing, secondary progressive multiple sclerosis (MS) to December 28, Sanofi said.
The agency also opted to not approve investigational apitegromab…